These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 25973089

  • 1. Significance of liver biopsy for the evaluation of methotrexate-induced liver damage in patients with rheumatoid arthritis.
    Osuga T, Ikura Y, Kadota C, Hirano S, Iwai Y, Hayakumo T.
    Int J Clin Exp Pathol; 2015; 8(2):1961-6. PubMed ID: 25973089
    [Abstract] [Full Text] [Related]

  • 2. Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment.
    Mori S, Arima N, Ito M, Fujiyama S, Kamo Y, Ueki Y.
    PLoS One; 2018; 13(8):e0203084. PubMed ID: 30142184
    [Abstract] [Full Text] [Related]

  • 3. Association between cumulative methotrexate dose, non-invasive scoring system and hepatic fibrosis detected by Fibroscan in rheumatoid arthritis patients receiving methotrexate.
    Lertnawapan R, Chonprasertsuk S, Siramolpiwat S.
    Int J Rheum Dis; 2019 Feb; 22(2):214-221. PubMed ID: 30565876
    [Abstract] [Full Text] [Related]

  • 4. [Methotrexate, liver and rheumatoid arthritis in tropical areas].
    Diouf ML, Diallo S, Mbengue M, Moreira-Diop T.
    Sante; 2001 Feb; 11(3):195-200. PubMed ID: 11641084
    [Abstract] [Full Text] [Related]

  • 5. Clinical liver disease in patients with rheumatoid arthritis taking methotrexate.
    Phillips CA, Cera PJ, Mangan TF, Newman ED.
    J Rheumatol; 1992 Feb; 19(2):229-33. PubMed ID: 1629819
    [Abstract] [Full Text] [Related]

  • 6. Methotrexate use in rheumatoid arthritis is associated with few clinically significant liver function test abnormalities.
    Yazici Y, Erkan D, Harrison MJ, Nikolov NP, Paget SA.
    Clin Exp Rheumatol; 2005 Feb; 23(4):517-20. PubMed ID: 16095122
    [Abstract] [Full Text] [Related]

  • 7. Massive intrahepatic hemorrhage following routine liver biopsy in a patient with rheumatoid arthritis treated with methotrexate.
    Cash JM, Swain M, Di Bisceglie AM, Wilder RL, Crofford LJ.
    J Rheumatol; 1992 Sep; 19(9):1466-8. PubMed ID: 1433018
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hepatotoxic potentials of methotrexate: Understanding the possible toxicological molecular mechanisms.
    Ezhilarasan D.
    Toxicology; 2021 Jun 30; 458():152840. PubMed ID: 34175381
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Autoimmune hepatitis after long-term methotrexate therapy for rheumatoid arthritis.
    Moreno-Otero R, García-Buey L, García-Sanchez A, Trapero-Marugán M.
    Curr Drug Saf; 2011 Jul 30; 6(3):197-200. PubMed ID: 22122395
    [Abstract] [Full Text] [Related]

  • 12. Hepatotoxicity rates do not differ in patients with rheumatoid arthritis and psoriasis treated with methotrexate.
    Amital H, Arnson Y, Chodick G, Shalev V.
    Rheumatology (Oxford); 2009 Sep 30; 48(9):1107-10. PubMed ID: 19578136
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The value of dynamic hepatic scintigraphy and serum aminoterminal propeptide of type III procollagen for early detection of methotrexate-induced hepatic damage in psoriasis patients.
    vanDooren-Greebe RJ, Kuijpers AL, Buijs WC, Kniest PH, Corstens FH, Nagengast FM, de Boo T, Willems JL, Duller P, van de Kerkhof PC.
    Br J Dermatol; 1996 Mar 30; 134(3):481-7. PubMed ID: 8731673
    [Abstract] [Full Text] [Related]

  • 16. "Hepatic toxicity by methotrexate with weekly single doses associated with folic acid in rheumatoid and psoriatic arthritis. What is its real frequency?".
    García DS, Saturansky EI, Poncino D, Martínez-Artola Y, Rosenberg S, Abritta G, Ascimani-Peña C, Cravero A.
    Ann Hepatol; 2019 Mar 30; 18(5):765-769. PubMed ID: 31105018
    [Abstract] [Full Text] [Related]

  • 17. Hepatic fibrosis in rheumatoid arthritis patients treated with methotrexate: application of a new semi-quantitative scoring system.
    Richard S, Guerret S, Gerard F, Tebib JG, Vignon E.
    Rheumatology (Oxford); 2000 Jan 30; 39(1):50-4. PubMed ID: 10662873
    [Abstract] [Full Text] [Related]

  • 18. Methotrexate therapy is not associated with increased liver stiffness and significant liver fibrosis in rheumatoid arthritis patients: A cross-sectional controlled study with real-time two-dimensional shear wave elastography.
    Erre GL, Cadoni ML, Meloni P, Castagna F, Mangoni AA, Piga M, Passiu G, Carru C, Zinellu A, Vidili G.
    Eur J Intern Med; 2019 Nov 30; 69():57-63. PubMed ID: 31474422
    [Abstract] [Full Text] [Related]

  • 19. Clinical, functional, and radiographic benefits of longterm adalimumab plus methotrexate: final 10-year data in longstanding rheumatoid arthritis.
    Keystone EC, van der Heijde D, Kavanaugh A, Kupper H, Liu S, Guérette B, Mozaffarian N.
    J Rheumatol; 2013 Sep 30; 40(9):1487-97. PubMed ID: 23818718
    [Abstract] [Full Text] [Related]

  • 20. A case of multiple hepatic lesions associated with methotrexate-associated lymphoproliferative disorder.
    Matsumoto R, Numata K, Doba N, Hara K, Chuma M, Fukuda H, Nozaki A, Tanaka K, Ishii Y, Maeda S.
    J Med Ultrason (2001); 2016 Oct 30; 43(4):545-51. PubMed ID: 27577564
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.